These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 72690)

  • 21. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism].
    Bürgi U; Gerber H; Peter HJ
    Schweiz Med Wochenschr; 1995 Aug; 125(31-32):1489-94. PubMed ID: 7545825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The significance of triiodothyronine in the evaluation of thyroid function after treatment for hyperthyroidism.
    Smeulers J; Docter R; Visser TJ; Hennemann G
    Neth J Med; 1980; 23(1):18-22. PubMed ID: 6154249
    [No Abstract]   [Full Text] [Related]  

  • 23. Ischemia-modified albümin and malondialdehyde levels in patients with overt and subclinical hyperthyroidism: effects of treatment on oxidative stress.
    Erem C; Suleyman AK; Civan N; Mentese A; Nuhoglu İ; Uzun A; Ersoz HO; Deger O
    Endocr J; 2015; 62(6):493-501. PubMed ID: 25843331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Thyroid hormone dynamics during the thyrostatic treatment of Basedow's disease].
    Vŭrbanov V; Zakharieva B; Manolov D; Zhelev N
    Vutr Boles; 1990; 29(1):68-73. PubMed ID: 1697716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Behavior of serum angiotensin converting enzyme in hyperthyroidism correlated to that of TSH].
    Letizia C; Sellini M; Baccarini S; Scavo D
    Minerva Med; 1991 Jun; 82(6):333-7. PubMed ID: 1712434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Morphology of functional disturbance of the thyroid (author's transl)].
    Böcker W
    Verh Dtsch Ges Pathol; 1977; 61():162-81. PubMed ID: 341570
    [No Abstract]   [Full Text] [Related]  

  • 27. [Four-year follow-up of thyrotoxic patients treated with antithyroid drugs bases on thyroid suppressibility-Prognostic value of the 20-min 131-I thyroid uptake (author's transl)].
    Leclere J; Ueda M; Hartemann P; Maureira JJ; Mizrahi R; Zannetti A; Weyland M; Vaillant D
    Ann Endocrinol (Paris); 1980; 41(2):95-105. PubMed ID: 6162414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Follow up studies of the antithyroid drug therapy for hyperthyroidism with special emphasis on the clinical usefulness of TRH and T3-suppression tests during treatment (author's transl)].
    Tamai H
    Fukuoka Igaku Zasshi; 1978 Nov; 69(11):486-94. PubMed ID: 83955
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of thyrotoxicosis based on thyroidal suppressiblity.
    Alexander WD; Harden RM; Shimmins J; McLarty D; McGill P
    Lancet; 1967 Sep; 2(7518):681-4. PubMed ID: 4167095
    [No Abstract]   [Full Text] [Related]  

  • 30. [Early histological changes of the thyroid gland sway the prognosis of juvenile thyrotoxicosis treated with antithyroid therapy (author's transl)].
    Takata I; Saida K; Suzuki Y; Sato T
    Horumon To Rinsho; 1979 Sep; 27(9):938-42. PubMed ID: 93525
    [No Abstract]   [Full Text] [Related]  

  • 31. [Diagnosis and therapy of hyperthyroidism].
    Schwarz K; Scriba PC
    Med Klin; 1969 Mar; 64(11):469-78. PubMed ID: 4181203
    [No Abstract]   [Full Text] [Related]  

  • 32. Antithyroid drugs and radioiodine therapy: a grain of (iodized) salt.
    Cooper DS
    Ann Intern Med; 1994 Oct; 121(8):612-4. PubMed ID: 7521993
    [No Abstract]   [Full Text] [Related]  

  • 33. Prediction of response to medical therapy by serum soluble (pro)renin receptor levels in Graves' disease.
    Mizuguchi Y; Morimoto S; Kimura S; Takano N; Yamashita K; Seki Y; Bokuda K; Yatabe M; Yatabe J; Watanabe D; Ando T; Ichihara A
    PLoS One; 2018; 13(4):e0195464. PubMed ID: 29621332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hyperthyroidism].
    Youlton R
    Rev Chil Pediatr; 1988; 59 Suppl 3():1-3. PubMed ID: 3271369
    [No Abstract]   [Full Text] [Related]  

  • 35. Hyperthyroidism is characterized by both increased sympathetic and decreased vagal modulation of heart rate: evidence from spectral analysis of heart rate variability.
    Chen JL; Chiu HW; Tseng YJ; Chu WC
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):611-6. PubMed ID: 16712661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapeutic indications in hyperthyroidism (author's transl)].
    Ermans AM
    Acta Chir Belg; 1978; 77(6):409-13. PubMed ID: 86256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The changes of serum titers of thyroid antibodies in patients of Graves' disease with hyperthyroidism after treatments with antithyroid drugs.
    Huang CS; Tseng FY; Chang TC; Chang CC; Chen FW; Torng JK
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1983 Nov; 16(4):277-82. PubMed ID: 6202467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities.
    Sgarbi JA; Villaça FG; Garbeline B; Villar HE; Romaldini JH
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1672-7. PubMed ID: 12679455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of neonatal hyperthyroidism in infants born to mothers with Graves disease.
    Skuza KA; Sills IN; Stene M; Rapaport R
    J Pediatr; 1996 Feb; 128(2):264-8. PubMed ID: 8636826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Respiratory muscle function and serum enzymology in hyperthyroidism before and after treatment].
    Yuan Y; He T; Zhang H; Luo Y; Zeng J; Tian H
    Hua Xi Yi Ke Da Xue Xue Bao; 1998 Jun; 29(2):204-8. PubMed ID: 10684017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.